Gene:
SCN5A
sodium channel, voltage-gated, type V, alpha subunit

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ? Function ? Amino Acid?
Translation
rs1805124 SCN5A:H558R, c.1673A>G, g.38585420T>C, g.38620424T>C, g.50744A>G, p.His558Arg T > C Missense His558Arg
No VIP available No Clinical Annotations available VA
rs1805125 G > A Missense Pro1089Leu
No VIP available No Clinical Annotations available VA
rs41313691 C > A Missense Ser524Tyr
No VIP available No Clinical Annotations available VA
rs41315493 G > T Missense Val1951Leu
rs6791924 SCN5A:R34C, c.100C>T, g.21465C>T, g.38614699G>A, p.Arg34Cys C > T Missense Arg34Cys
rs7626962 SCN5A:S1103Y, c.3228+1515C>A, c.3305C>A, c.3308C>A, g.38560907G>A, g.38560907G>C, g.38560907G>T, g.38595911G>T, g.75257C>A, p.Ser1102Tyr, p.Ser1103Tyr C > A Missense Ser1102Tyr
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  OTTHUMP00000209279; OTTHUMP00000209280; OTTHUMP00000209281; OTTHUMP00000209282; OTTHUMP00000209283; OTTHUMP00000209284; Sodium channel, voltage-gated, type V, alpha polypeptide; cardiac sodium channel alpha subunit; cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit; cardiomyopathy, dilated 1E (autosomal dominant); sodium channel protein cardiac muscle subunit alpha; sodium channel protein type 5 subunit alpha; sodium channel protein type V alpha subunit; sodium channel protein type V subunit alpha; sodium channel, voltage-gated, type V, alpha (long QT syndrome 3); sodium channel, voltage-gated, type V, alpha polypeptide (long (electrocardiographic) QT syndrome 3); voltage-gated sodium channel subunit alpha Nav1.5; voltage-gated sodium channel type V alpha
Alternate Symbols:  CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1
Haplotypes: SCN5A Haplotype A; SCN5A Haplotype B; SCN5A Haplotype C
PharmGKB Accession Id: PA304

Details

Cytogenetic Location: chr3 : p22.2 - p22.2
GP mRNA Boundary: chr3 : 38589553 - 38691163
GP Gene Boundary: chr3 : 38586553 - 38701163
Strand: minus
Product Name: cardiac sodium channel alpha subunit, cardiomyopathy, dilated 1E (autosomal dominant), sodium channel, voltage-gated, type V, alpha polypeptide (long (electrocardiographic) QT syndrome 3), voltage-gated sodium channel type V alpha, voltage-gated sodium channel type V alpha isoform a, voltage-gated sodium channel type V alpha isoform b
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

All alleles are displayed on the positive chromosomal strand.

Download Haplotype Data (CSV)

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Antiarrhythmic Pathway, Pharmacodynamics
    Pharmacodynamic pathway of antiarrhythmic drugs in a stylized cardiac myocyte.

External Pathways

Links to non-PharmGKB pathways.

PharmGKB contains no links to external pathways for this gene. To report a pathway, click here.

No related genes are available.

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information ?

Drug Class Relationship Evidence
antiarrhythmics, class i and iii
  •   
  •   
Publications
antipsychotics
  • PD
  •   
Publications
Beta blocking agents, selective
  • PD
  •   
Publications
qt-prolonging drugs
  • PD
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information ?

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other diseases is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.